Table 4.
Criterion | Correlation with the PQI total score | Corrected item total correlation | Cronbach's α if item deleted |
---|---|---|---|
1. Indication | 0.6b** | 0.5 | 0.5 |
2. Dosage | 0.6b** | 0.3 | 0.6 |
3. Effectiveness | 0.4b** | 0.4 | 0.6 |
4. Evidence-based | 0.3b** | 0.3 | 0.6 |
5. Correct directions | 0.3b** | 0.1 | 0.6 |
6. Practical directions | 0.4b** | 0.2 | 0.6 |
7. Drug–drug interactions | 0.4b** | 0.1 | 0.6 |
8. Drug–disease/condition interactions | 0.4b** | 0.4 | 0.6 |
9. Adverse drug reaction | 0.4b** | 0.3 | 0.6 |
10. Unnecessary duplication | 0.1b | 0.0 | 0.6 |
11. Duration of therapy | 0.4b** | 0.4 | 0.6 |
12. Cost | 0.3b** | 0.1 | 0.6 |
13. Generic prescribing | 0.4a** | 0.2 | 0.6 |
14. Formulary or essential drug list | 0.1b | 0.0 | 0.6 |
15. Compliance | 0.3b** | 0.2 | 0.6 |
16. Medication's name | 0.3b** | 0.2 | 0.6 |
17. Legibility | 0.1b | 0.1 | 0.6 |
18. Prescriber's information | 0.3b** | 0.0 | 0.6 |
19. Patient's information | 0.2b | 0.0 | 0.6 |
20. Diagnosis | 0.4a** | 0.2 | 0.6 |
21. Requirement for drug therapy | 0.2b* | 0.2 | 0.6 |
22. Patient's improvement | 0.2b* | 0.1 | 0.6 |
Correlation significant at 0.01 level (two-tailed).
Correlation significant at 0.05 level (two-tailed).
Pearson correlation.
Spearman's ρ.